NIA Impact Advisors’s GSK GSK Stock Holding History

NIA Impact Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.34M	Sell	121,036 -601	-0.5%	-$31.8K	2.63%	9
2026 Q1	$6.71M	Sell	121,637 -4,970	-4%	-$269K	2.98%	9
2025 Q4	$6.21M	Buy	126,607 +16,432	+15%	+$766K	2.08%	13
2025 Q3	$4.76M	Buy	110,175 +1,479	+1%	+$57.8K	1.55%	24
2025 Q2	$4.17M	Sell	108,696 -331	-0.3%	-$12.6K	1.44%	26
2025 Q1	$4.22M	Buy	+109,027	New	+$3.99M	1.57%	21
2023 Q1	–	Sell	-7,166	Closed	-$252K	–	64
2022 Q4	$252K	Sell	7,166 -5,052	-41%	-$168K	0.15%	51
2022 Q3	$360K	Sell	12,218 -79,534	-87%	-$3.01M	0.22%	52
2022 Q2	$4.99M	Buy	91,752 +28,316	+45%	+$1.56M	3%	9
2022 Q1	$3.45M	Buy	+63,436	New	+$3.45M	1.67%	18

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

NIA Impact Advisors's GSK Position: Q2 2026 in Review

NIA Impact Advisors reduced its GSK (GSK) stake by 0.49% in Q2 2026, selling an estimated $31.8K and leaving 121,036 shares worth $6.34M. The position accounts for 2.63% of the portfolio, ranked #9.

NIA Impact Advisors first reported a position in GSK in Q1 2022 and has held it in 10 quarters since. The position peaked at $6.71M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

NIA Impact Advisors held 121,036 shares of GSK worth $6.34M as of Q2 2026.
NIA Impact Advisors sold 601 GSK shares in Q2 2026, an estimated $31.8K.
GSK made up 2.63% of NIA Impact Advisors's portfolio in Q2 2026, its #9 holding.
NIA Impact Advisors first reported a position in GSK in Q1 2022 and has held it in 10 quarters since.
NIA Impact Advisors's GSK position peaked at $6.71M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.